Cargando…
Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267524/ https://www.ncbi.nlm.nih.gov/pubmed/37325496 http://dx.doi.org/10.1159/000527250 |
| _version_ | 1785058946838429696 |
|---|---|
| author | Matsuki, Ryota Okano, Naohiro Hasui, Nobuhiro Kawaguchi, Shohei Momose, Hirokazu Kitahama, Keiichiro Nagahama, Kiyotaka Kogure, Masaharu Suzuki, Yutaka Nagashima, Fumio Shibahara, Junji Mori, Hideaki Sakamoto, Yoshihiro |
| author_facet | Matsuki, Ryota Okano, Naohiro Hasui, Nobuhiro Kawaguchi, Shohei Momose, Hirokazu Kitahama, Keiichiro Nagahama, Kiyotaka Kogure, Masaharu Suzuki, Yutaka Nagashima, Fumio Shibahara, Junji Mori, Hideaki Sakamoto, Yoshihiro |
| author_sort | Matsuki, Ryota |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10267524 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | S. Karger AG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102675242023-06-15 Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression Matsuki, Ryota Okano, Naohiro Hasui, Nobuhiro Kawaguchi, Shohei Momose, Hirokazu Kitahama, Keiichiro Nagahama, Kiyotaka Kogure, Masaharu Suzuki, Yutaka Nagashima, Fumio Shibahara, Junji Mori, Hideaki Sakamoto, Yoshihiro Liver Cancer Letter to the Editor S. Karger AG 2022-10-25 /pmc/articles/PMC10267524/ /pubmed/37325496 http://dx.doi.org/10.1159/000527250 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. |
| spellingShingle | Letter to the Editor Matsuki, Ryota Okano, Naohiro Hasui, Nobuhiro Kawaguchi, Shohei Momose, Hirokazu Kitahama, Keiichiro Nagahama, Kiyotaka Kogure, Masaharu Suzuki, Yutaka Nagashima, Fumio Shibahara, Junji Mori, Hideaki Sakamoto, Yoshihiro Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title | Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title_full | Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title_fullStr | Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title_full_unstemmed | Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title_short | Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression |
| title_sort | atezolizumab and bevacizumab combination therapy and sequential conversion hepatectomy for advanced fibrolamellar hepatocellular carcinoma presenting pseudoprogression |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267524/ https://www.ncbi.nlm.nih.gov/pubmed/37325496 http://dx.doi.org/10.1159/000527250 |
| work_keys_str_mv | AT matsukiryota atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT okanonaohiro atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT hasuinobuhiro atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT kawaguchishohei atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT momosehirokazu atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT kitahamakeiichiro atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT nagahamakiyotaka atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT koguremasaharu atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT suzukiyutaka atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT nagashimafumio atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT shibaharajunji atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT morihideaki atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression AT sakamotoyoshihiro atezolizumabandbevacizumabcombinationtherapyandsequentialconversionhepatectomyforadvancedfibrolamellarhepatocellularcarcinomapresentingpseudoprogression |